ADA 2026: TRANSCEND-T2D-1: Retatrutide Demonstrates Robust Reductions in HbA1c and Body Weight as Monotherapy in Type 2 Diabetes The phase 3 TRANSCEND-T2D-1 trial evaluated the triple GIP, GLP-1, and glucagon receptor agonist in adults with type 2 diabetes inadequately controlled with diet and exercise alone
Nutritional Deficiencies Semaglutide works by reducing appetite, which can lead to lower calorie intake
Optum, for example, has 15 Optum Specialty Pharmacies and two Optum Frontier Therapies that the company says help patients with rare and complex conditions, helping them access more than 200 specialty drugs
When needed, youll pay separately for testing
A balanced diet with lean protein, vegetables, whole grains, and healthy fats supports sustained weight loss